Industry NewsPfizer and IDA Foundation partner to expand access to essential cancer treatments low-and middle-income countries
Product NewsDiaSorin launches LIAISON SARS-CoV-2 TrimericS IgG test for determination of IgG antibodies
Expert InsightsReliable and rapid antimicrobial resistance identification for appropriate therapy: Your questions answered
Industry NewsViiV Healthcare announces FDA approval of the first complete long-acting regimen for HIV treatment
Industry NewsSyntekabio, Hanmi Science collaborate to develop COVID-19 treatments using drug repurposing technologies
Industry NewsUniversity of Bern establishes a multidisciplinary center for research into infectious diseases and immunity
Product NewsMission Bio launches single-cell multi-omics system for faster development of precision cancer therapies
Industry NewsPfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize coronavirus mutations
Industry NewsAbivax’s COVID-19 phase 2b/3 trial with ABX464 declared research national priority by the French government’s clinical trial council
Industry NewsRoche receives FDA authorization for semi-quantitative test to measure the level of SARS-CoV-2 antibodies
Expert InsightsInvestigating traditional and modern approaches to antimicrobial susceptibility testing
Industry NewsNew clinical trial data demonstrates BD Libertas™ Wearable Injector as a drug delivery system
